Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Carsten Schwenke , Monica Boos , Rainer Hentrich , et al Added: 3 years ago
Since its introduction in 1993,1 contrast-enhanced magnetic resonance angiography (ce-MRA) has been considered the technique of choice for angiographic examination of most regions of the body. This is because of several technical and clinical advantages in comparison with non-contrast-enhanced MRA (nce-MRA) imaging. In this article, we focus on patients with suspected peripheral arterial… View more

Imaging & Diagnostics
Author(s): Tim Leiner , Susanne Kienbaum Added: 3 years ago
Peripheral arterial occlusive disease (PAOD) is a major health risk. The prevalence of PAOD varies with the population observed and the screening method used. In epidemiological studies, measurement of the ankle/brachial index (ABI) is recommended for screening (ABI <0.9 indicates PAOD). Surveys in Germany based on the ABI showed a PAOD prevalence of 2.3% among women aged 45–49 years and of 2… View more

Imaging & Diagnostics
The FISH&CHIPS Study: Real-world Study Reveals Significant Reduction in All-cause and Cardiovascular Mortality
Author(s): Jonathon A Leipsic Added: 5 months ago
FISH&CHIPS two-year key outcomes associated with availability of FFRCT include:A significant 14% relative reduction in cardiovascular mortality and a significant 8% relative reduction in all-cause mortality.An increase in cath lab efficiency, driven by a 5% relative reduction in invasive cardiac angiography (ICA) and an 8% relative increase in Percutaneous Coronary Intervention (PCI).A 14%… View more

Standards & Guidelines

Imaging & Diagnostics
Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
Author(s): Nikita Lomakin , Anna Rudakova , Liudmila Buryachkovskaya , et al Added: 3 years ago
Antiplatelet agents are part of secondary prevention following acute coronary syndrome (ACS). Current European and Russian guidelines recommend dual antiplatelet therapy for 1 year after ACS.1,2 Prasugrel is not marketed in Russia, so high-risk patients have been given ticagrelor. The proportion of generic clopidogrel administered has been steadily rising, with the average cost of treatment… View more

Anticoagulation

MI/ACS
Author(s): David E Allie , Chris J Herbert , Craig M Walker Added: 3 years ago
Despite the recent introduction of vascular closure device (VCD) technology, vascular access site complications remain the leading source of morbidity and costs after the approximately eight to eight-and-a-half million percutaneous catheter-based procedures performed annually worldwide. VCD trials consistently demonstrate increased patient satisfaction, early ambulation, and decreased hospital… View more

Intervention
Author(s): Rosa Sicari , Lauro Cortigiani Added: 3 years ago
In 2007, the American College of Cardiology Foundation (ACCF), in partnership with the American Society of Echocardiography, published appropriateness criteria for transthoracic echocardiography (TTE)1 and, a year later, appropriateness criteria for stress echocardiography.2 Both sets of criteria have been updated and combined into a single, recently published document.3 It remains a work in… View more

Imaging & Diagnostics
Author(s): Omar Abdulla Added: 3 years ago
Coronary artery disease (CAD) is the leading cause of death in the US, and accounts for approximately US$100 billion in healthcare costs every year.1 Metabolic syndrome describes a combination of medical disorders that increase the risk of developing cardiovascular disease (CVD).2 Risk factors include central obesity, hypercholesterolaemia, hypertension and insulin resistance or glucose… View more

Prevention & Chronic Conditions
Improving overall efficiencies in the cardiology care pathway
Author(s): Tom De Potter , Miel Dabush , Gad Keren Start date: Apr 30, 2020

Prevention & Chronic Conditions
Foreword

Article

Added: 3 years ago
Cardiovascular diseases (CVD) remains a major challenge in contemporary medicine, predominantly in the Western, 'developed' world. Socioeconomic development will also lead to a further increase in CVD in currently 'underdeveloped' regions. We therefore have to expect an increasing number of CVD cases due to higher life expectancy and an improvement of socioeconomic status particularly in Asia,… View more
AI powered CT based Non Invasive CAD testing
Author(s): Derek Connolly , , Added: 2 years ago
According to NICE,HeartFlow FFRct should be considered as an option for patients with stable, recent-onset chest pain who are offered CCTA. Using HeartFlow FFRct may avoid the need for invasive coronary angiography and revascularisation. Based on the current evidence and assuming there is access to appropriate CCTA facilities, using HeartFlow FFRct may lead to cost savings of £391 per… View more

Imaging & Diagnostics

Prevention & Chronic Conditions